| AMPK | AMP kinase |
| AQP-4 | Aquaporin-4 |
| BHB | β-hydroxybutyrate |
| CD86 | Cluster of Differentiation 86 |
| CKD | Classic ketogenic diet |
| CNS | Central nervous system |
| COX-2 | Prostaglandin-endoperoxide synthase 2 |
| CR | Caloric restriction |
| CT | Chemotherapy |
| DON | 6-diazo-5-oxo-1-norleucine |
| DVT | Deep vein thrombosis |
| EFSA | European Food Safety Authority |
| EGF | Epidermal growth factor |
| EPO | Erythropoietin |
| GABA | Gamma-aminobutyric acid |
| GBM | Glioblastoma multiforme |
| GHS | Global health status |
| GLUT | Glucose transporter |
| HIF-1 | Hypoxia-inducible factor 1 |
| IDH | Isocitrate dehydrogenase |
| IGF-1 | Insulin-like growth factor 1 |
| KB | Ketone bodies |
| KD | Ketogenic diet |
| LKB1 | Serine/threonine kinase 11 (STK11), also known as liver kinase B1 (LKB1) |
| MAD | Modified Atkins diet |
| MCT | Medium-chain triglyceride |
| MCTs | Monocarboxylate transporter |
| miRNAs | microRNAs |
| MKD | Modified ketogenic diet |
| MMP | Matrix metalloproteinases |
| NF-kB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NLRP3 | NLR family pyrin domain containing 3 |
| NOS | Nitric oxide synthase |
| NSAID | Non-steroidal anti-inflammatory drugs |
| PD-L1 | Programmed death-ligand 1 |
| PDGFR | Platelet-derived growth factor receptors |
| PHD | Pyruvate dehydrogenase complex |
| PFS | Progression-free survival |
| PI3K | Phosphoinositide 3-kinases |
| ROS | Reactive oxygen species |
| RT | Radiotherapy |
| SD | Standard diet |
| TNF-alpha | Tumor necrosis factor alpha |
| UCP-2 | Mitochondrial uncoupling protein |
| VEGF | Vascular-endothelial growth factor |
| VLCKD | Very low-calorie ketogenic diet |